The Ugly Truth About Xarelto Lawsuit

by VadaClifford847 posted Apr 22, 2017
?

단축키

Prev이전 문서

Next다음 문서

ESC닫기

크게 작게 위로 아래로 댓글로 가기 인쇄 수정 삭제
Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to accomplish so could be grounds for compensation. Our lawyers are working difficult to obtain those hurt by the drug the compensation they are entitled to.

Although bleeding can be a frequent complication related with anticoagulants, it has been alleged that Xarelto is far more hazardous than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, patients could be at threat for irreversible bleeding troubles, including life-threatening internal and gastrointestinal hemorrhaging.

Should you or possibly a loved one suffered a serious bleeding occasion soon after taking Xarelto, you might have legal recourse. For much more info, speak to us right now to have your case reviewed, totally free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in instances of death, funeral costs. Moreover, they're looking for punitive damages, which are generally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked navigate to this web-site critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for much more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Articles

3 4 5 6 7 8 9 10 11 12